M Burnier,M Maillard
M Burnier
Losartan, the first angiotensin II receptor antagonist was introduced in 1994. Since then, five other antagonists have been launched for the management of hypertension. In recent years, numerous studies have demonstrated that angiotensin II...
Frontiers in pharmacology and therapeutics in the 21st century--International Congress. 1-4 December, 1999, New Delhi, India [0.03%]
21世纪的药理学和治疗学进展国际大会印度新德里1999年12月1～4日
S B Vohora,D Vohora,S Raisuddin
S B Vohora
Breast cancer--22nd annual symposium. 8-11 December 1999, San Antonio, TX, USA [0.03%]
乳腺癌――第22届年度研讨会。1999年12月8－11日，美国德克萨斯州圣安东尼奥市
J Stebbing
J Stebbing
This symposium focused on trials conducted primarily on patients with metastatic breast cancer with the aim of defining the safest and most effective treatment regimens. The combination of paclitaxel and doxorubicin procured a survival adva...
Osteoporosis therapies--future leads and current clinical trials. 13-14 December 1999, London, UK [0.03%]
骨质疏松症疗法——未来前景和当前临床试验。1999年12月13至14日，伦敦，英国
S Bennett
S Bennett
This IBC conference focused on research areas most likely to generate novel leads for future osteoporosis therapies. There was particular emphasis placed on inhibitors of bone resorption, including progress in the development of existing co...
Drug Delivery Systems--Fifth US-Japan Symposium. 12-17 December 1999, Lahaina, Hawaii [0.03%]
药剂输送体系第五届美国-日本学术会议1999年12月12～17日夏威夷拉海纳镇
L I Wiebe
L I Wiebe
The field of drug delivery is moving rapidly from the more efficacious delivery of 'old' drugs, to the delivery of therapeutic peptides, proteins, oligonucleotides and genes. Liposomes, polymers, microbubbles, nanoparticles, wafers and chip...